A Phase II Trial of Doxorubicin and Genexol-PM in Patients With Advanced Breast Cancer
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer
Interventions: DRUG: Doxorubicin/Genexol-PM
Sponsor: Gachon University Gil Medical Center